What is the recommended topical treatment for impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Topical Treatment of Impetigo

Topical mupirocin 2% ointment applied twice daily for 5 days is the recommended first-line treatment for localized, uncomplicated impetigo. 1

Causative Organisms and Diagnosis

Impetigo is a highly contagious, superficial skin infection caused by:

  • Staphylococcus aureus (most common)
  • Streptococcus pyogenes (Group A streptococcus)
  • Or both organisms simultaneously

There are two main types:

  • Nonbullous impetigo (70% of cases): characterized by honey-colored crusts
  • Bullous impetigo (30% of cases): characterized by flaccid bullae, exclusively caused by S. aureus

While Gram stain and culture can help identify the causative organism, treatment without these studies is reasonable in typical cases 1.

Treatment Algorithm

1. Localized, Uncomplicated Impetigo

  • First-line therapy: Topical mupirocin 2% ointment applied twice daily for 5 days 1, 2

    • FDA-approved specifically for impetigo
    • Clinical efficacy rates of 71-93% in clinical trials 2
    • Complete the full course even if lesions improve earlier 3
  • Alternative topical option: Retapamulin applied twice daily for 5 days 1

2. When to Use Oral Antibiotics Instead

Oral antibiotics are recommended when:

  • Patient has numerous or widespread lesions
  • During outbreaks affecting several people (to decrease transmission)
  • Signs of systemic illness are present
  • Significant lymphadenopathy is present
  • Infection fails to respond to topical therapy after 3-4 days
  • Multiple household members are affected 1, 3

3. Oral Antibiotic Options (7-day regimen)

  • For methicillin-susceptible S. aureus: Dicloxacillin or cephalexin 1
  • For MRSA (suspected or confirmed): Doxycycline, clindamycin, or sulfamethoxazole-trimethoprim (SMX-TMP) 1
  • For streptococci alone: Oral penicillin 1

Efficacy Considerations

Topical mupirocin has been shown to be:

  • As effective as oral erythromycin in clinical trials (93% vs 78.5% efficacy) 2
  • Effective at pathogen eradication (94-100% in clinical trials) 2
  • Similar in efficacy to other topical agents like fusidic acid against S. aureus, but superior against S. pyogenes 4

Important Clinical Pearls

  • Duration of therapy: Complete the full 5-day course even if lesions appear to be improving earlier 3
  • Expected response: Improvement should be seen within 3-4 days of starting treatment 3
  • Prevention of spread: Regular bathing, avoiding sharing personal items, and washing hands frequently can help prevent transmission 3
  • Household management: Consider evaluating household contacts for similar infections to prevent further spread 3
  • Complications: While rare, the most serious potential complication is poststreptococcal glomerulonephritis 5
  • Antibiotic resistance: Be aware of increasing prevalence of resistant bacteria, including MRSA, macrolide-resistant streptococcus, and mupirocin-resistant strains 5

Special Considerations

  • Pediatric patients: Mupirocin is effective and well-tolerated in children as young as 2 months 2
  • Systemic therapy preference: During outbreaks affecting multiple people, systemic therapy is preferred to help decrease transmission 3
  • Topical disinfectants: These are inferior to antibiotics and should not be used 5, 6

By following this treatment algorithm, most cases of impetigo will resolve within 2-3 weeks without scarring, with significant improvement typically seen within 3-4 days of initiating appropriate therapy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Bacterial Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Research

Diagnosis and treatment of impetigo.

American family physician, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.